SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-007316
Filing Date
2023-03-13
Accepted
2023-03-13 06:05:17
Documents
12
Period of Report
2023-03-13
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 32775
  Complete submission text file 0001493152-23-007316.txt   211485

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT glsi-20230313.xsd EX-101.SCH 3266
3 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT glsi-20230313_lab.xml EX-101.LAB 34916
4 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT glsi-20230313_pre.xml EX-101.PRE 22815
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3876
Mailing Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477
Business Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477 203-434-3290
Greenwich LifeSciences, Inc. (Filer) CIK: 0001799788 (see all company filings)

IRS No.: 205473709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39555 | Film No.: 23725558
SIC: 2834 Pharmaceutical Preparations